Glaucoma
Welcome,         Profile    Billing    Logout  
 90 Companies   65 Products   65 Products   50 Mechanisms of Action   808 Trials   63350 News 


«12...686687688689690691692693694695696...706707»
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Safety Study of Latanoprost Slow Release Insert (clinicaltrials.gov) -  Dec 9, 2014   
    P1,  N=12, Terminated, 
    Active, not recruiting --> Completed N=15 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Jun 2014; Study terminated early due to manufacturer not replenishing study site supply of inserts, despite repeated requests for more inserts.
  • ||||||||||  Phase classification:  Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension (clinicaltrials.gov) -  Dec 9, 2014   
    P4,  N=600, Enrolling by invitation, 
    N=15 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Jun 2014; Study terminated early due to manufacturer not replenishing study site supply of inserts, despite repeated requests for more inserts. Phase classification: P=N/A --> P4
  • ||||||||||  bamosiran (SYL040012) / PharmaMar
    Enrollment open:  SYLTAG: SYL040012, Treatment for Open Angle Glaucoma (clinicaltrials.gov) -  Dec 7, 2014   
    P2,  N=180, Recruiting, 
    N=30 --> 45 Not yet recruiting --> Recruiting
  • ||||||||||  Trial primary completion date, HEOR:  Multicentric Observational Study on Quality of Life in Glaucoma (clinicaltrials.gov) -  Dec 6, 2014   
    P=N/A,  N=3170, Active, not recruiting, 
    Recruiting --> Completed | N=60 --> 41 Trial primary completion date: Oct 2014 --> Feb 2015
  • ||||||||||  Trial primary completion date:  Novel Glaucoma Diagnostics (clinicaltrials.gov) -  Dec 5, 2014   
    P=N/A,  N=500, Recruiting, 
    N=50 --> 12 | Recruiting --> Terminated | Trial primary completion date: Nov 2012 --> Feb 2012; short of study staff Trial primary completion date: May 2012 --> May 2017
  • ||||||||||  timolol maleate ophthalmic solution / Generic mfg., travoprost ophthalmic / Generic mfg.
    Trial initiation date:  Efficacy of Changing to DuoTrav (clinicaltrials.gov) -  Dec 5, 2014   
    P4,  N=37, Terminated, 
    Trial primary completion date: May 2012 --> May 2017 Initiation date: Oct 2012 --> Jun 2012
  • ||||||||||  Enrollment open, Trial initiation date, Biopsy:  Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies (clinicaltrials.gov) -  Dec 5, 2014   
    P=N/A,  N=20, Recruiting, 
    Initiation date: Oct 2012 --> Jun 2012 Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Dec 2014
  • ||||||||||  Enrollment change:  Clinical Study of the Optic Disc Parameters (clinicaltrials.gov) -  Nov 27, 2014   
    P=N/A,  N=100, Recruiting, 
    Active, not recruiting --> Completed N=80 --> 100
  • ||||||||||  timolol maleate ophthalmic solution / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  Effect of Topical Glaucoma Therapy on Tear Film Stability in Healthy Subjects (clinicaltrials.gov) -  Nov 25, 2014   
    P3,  N=38, Terminated, 
    N=80 --> 100 N=120 --> 38 | Recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Sep 2012
  • ||||||||||  Enrollment closed, Trial primary completion date:  A Study of GANFORT (clinicaltrials.gov) -  Nov 24, 2014   
    P=N/A,  N=2000, Active, not recruiting, 
    N=120 --> 38 | Recruiting --> Terminated | Trial primary completion date: Mar 2014 --> Sep 2012 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Nov 2014
  • ||||||||||  rosuvastatin / Generic mfg.
    Enrollment change, Trial withdrawal, Trial primary completion date:  Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma (clinicaltrials.gov) -  Nov 23, 2014   
    P4,  N=0, Withdrawn, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Nov 2014 N=80 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Apr 2010 --> Nov 2014
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Progressive Open Angle Glaucoma (OAG) and Ocular Blood Flow (clinicaltrials.gov) -  Nov 23, 2014   
    P=N/A,  N=0, Withdrawn, 
    N=80 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Apr 2010 --> Nov 2014 N=200 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Nov 2008 --> Nov 2014
  • ||||||||||  Enrollment change, Trial initiation date, Trial termination, Trial primary completion date:  Neurovascular Coupling in Patients With Open Angle Glaucoma (clinicaltrials.gov) -  Nov 23, 2014   
    P=N/A,  N=15, Terminated, 
    N=200 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Nov 2008 --> Nov 2014 N=60 --> 15 | Initiation date: Jun 2004 --> Oct 2006 | Recruiting --> Terminated | Trial primary completion date: Dec 2009 --> Apr 2007
  • ||||||||||  ethacrynic acid / Generic mfg.
    Enrollment open:  Novel Drug Delivery Technique Via Retroject Device (clinicaltrials.gov) -  Nov 23, 2014   
    P1/2,  N=20, Recruiting, 
    N=54 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2009 --> Nov 2014 Not yet recruiting --> Recruiting
  • ||||||||||  Trial primary completion date:  External Influences Upon Ocular Homeostasis (clinicaltrials.gov) -  Nov 19, 2014   
    P=N/A,  N=200, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Evaluation of Objective Perimetry Using Pupillometer (clinicaltrials.gov) -  Nov 19, 2014   
    P=N/A,  N=60, Completed, 
    Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Completed | Trial primary completion date: Nov 2010 --> Jan 2013
  • ||||||||||  Trial completion:  PIO laser SPNP: PIO Laser Sclerectomy IOP SLT Sclerectomy (clinicaltrials.gov) -  Nov 17, 2014   
    P=N/A,  N=26, Completed, 
    N=77 --> 35 | Recruiting --> Terminated; Lack of funding Recruiting --> Completed
  • ||||||||||  Combigan (brimonidine tartrate/timolol maleate) / AbbVie
    Trial completion, Enrollment change:  Effect of Xalacom (clinicaltrials.gov) -  Nov 14, 2014   
    P=N/A,  N=16, Completed, 
    Recruiting --> Completed Recruiting --> Completed | N=20 --> 16
  • ||||||||||  Enrollment open:  Health Coaching for Glaucoma Patients (clinicaltrials.gov) -  Oct 23, 2014   
    P=N/A,  N=10, Recruiting, 
    Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
  • ||||||||||  Enrollment closed, Trial primary completion date:  The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study (clinicaltrials.gov) -  Oct 23, 2014   
    P=N/A,  N=80, Active, not recruiting, 
    Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Dec 2014
  • ||||||||||  Lumigan (bimatoprost) / Senju, AbbVie
    Trial primary completion date:  Safety and Efficacy Assessment of Monoprost (clinicaltrials.gov) -  Oct 17, 2014   
    P4,  N=396, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Dec 2014 Trial primary completion date: Sep 2014 --> Dec 2015